Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) today announced positive top-line results from three Phase III clinical studies designed to evaluate ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE